Mestinon
Mestinon is an originator product from MEDA Pharmaceuticals Switzerland GmbH and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 31.00 to CHF 58.85 depending on the pack; the patient co-payment is 10 per cent plus the deductible.
Core data
- Authorisation holder
- MEDA Pharmaceuticals Switzerland GmbH
- ATC code
- N07AA02
- IT group
- 01.14 Myasthenia gravis
- Active substances
- Pyridostigmini bromidum
- Preparation type
- Originator product
- On the SL since
- 15/03/1996
- Last price change
- 01/12/2021
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Tabl 10 mg | 250 Stk | CHF 13.43 | CHF 31.00 | 15/03/1996 | B | 7680199450225 |
| Drag 60 mg | 150 Stk | CHF 39.02 | CHF 58.85 | 15/03/1996 | B | 7680199430388 |
Limitation
No limitation is recorded on the SL for this preparation.
FAQ
Is Mestinon covered by Swiss health insurance?
Yes. Mestinon is on the FOPH Specialities List, so Swiss mandatory health insurance reimburses it within the authorised indication. You still pay the deductible and a co-payment of 10 per cent.
What does Mestinon cost in Switzerland?
The public price is the maximum price set by the FOPH and for Mestinon ranges from CHF 31.00 to CHF 58.85 per pack. The ex-factory price ranges from CHF 13.43 to CHF 39.02. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages